Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC

Clinical trial NCT05000736 · UNKNOWN

Trial details

NCT number: NCT05000736
Sponsor: Chinese Academy of Medical Sciences
Status: UNKNOWN
Study type: OBSERVATIONAL

Hormone Receptor Positive Advanced Breast Cancer

Start date: 2021-09-01
Primary completion: 2022-09-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.